Gal et al address the issues raised by Gerber et al and reiterate that patients in
their study showed decreased Misato homolog 1 (MSTO1) mRNA and protein levels, but
also confirm finding of Gerber et al that the mutation is in MSTO2p pseudogene. Whether
MSTO2p variant contributes to the observed decrease in MSTO1 levels in patients remains
unclear.
